Status:
COMPLETED
A Study of Gaboxadol in Primary Insomnia
Lead Sponsor:
H. Lundbeck A/S
Conditions:
Primary Insomnia
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
To evaluate the safety and tolerability of gaboxadol in primary insomnia.
Detailed Description
To obtain long-term safety and tolerability data with gaboxadol.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- patients with Primary insomnia
Exclusion
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
End Date :
March 1 2005
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00209963
Start Date
June 1 2003
End Date
March 1 2005
Last Update
March 30 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.